Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.12 (
biotinidase
)
392
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Biotinidase was purified from human breast milk (4,000-fold), and was compared with human serum
biotinidase
(enriched 30,000-fold). The molecular weight of milk enzyme was 68,000 Da as determined by SDS-PAGE. It was definitely smaller than that of serum
biotinidase
(Mr = 76,000). Isoelectric point of milk
biotinidase
was 4.6, whereas that of serum
biotinidase
was 4.3.
Sialic acid
content in milk
biotinidase
was less than that found in serum enzyme. N-Acetyl-galactosamine was present in milk enzyme, whereas it was absent in serum enzyme. Milk
biotinidase
is O-glycosylated, whereas serum
biotinidase
is N-glycosylated. These differences in glycosylation suggest the existence of different types of excretion mechanisms between milk and serum
biotinidase
. Both biotinidases were found to be thiol-type enzyme, however, the extent of activation of the enzyme by 2-mercaptoethanol was 13-fold in milk, whilst the serum enzyme was activated only 1.5-fold. Km for biotinyl-4-amino-benzoate was 22 microM in milk enzyme and 50 microM in serum enzyme. Competitive inhibition by biotin (Ki) of milk enzyme was 43 microM and 1.3 mM for serum enzyme. These results suggest the structural differences at or near the active site of the each enzyme.
...
PMID:Comparative study on human milk and serum biotinidase. 251 77